Drug recall · November 27, 2024
Xelstrym recall
Why: Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside a foil-sealed polypropylene tray, packed in a paper carton/box, MANUFACTURED BY NOVEN PHARMACEUTICALS, INC., Miami, FL 33186 United Sates, NDC 68968-0215-3
- Lots / codes
Lot # 95598, Exp 02/28/25
- Quantity
- 685 boxes
- Company
- Noven Pharmaceuticals Inc, Miami, FL
- Distribution
- USA nationwide.
- Initiated
- October 31, 2024 · Voluntary: Firm initiated
- Classified
- November 19, 2024
- Reported
- November 27, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Xelstrym
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.